Want to see IL:HARL full AI Analyst Report?
Harel (HARL) AI Stock Analysis
Top Page
Harel
(TASE:HARL)
The score is driven primarily by improved profitability and strong ROE, tempered by rising leverage and uneven cash-flow generation. Technicals are constructive with price above key moving averages, though overbought signals add near-term risk. Valuation is supportive with a reasonable P/E and an attractive dividend yield.
Harel (HARL) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 37.10B
- Dividend Yield
- 3.85%
- Average Volume (3M)
- 308.77K
- Price to Earnings (P/E)
- 11.3
- Beta (1Y)
- 1.47
- Revenue Growth
- 14.74%
- EPS Growth
- 70.44%
- Country
- Israel
- Employees
- 5,000
- Sector
- General
- Sector Strength
- 55
- Industry
- Insurance - Diversified
Harel Business Overview & Revenue Model
Company Description
Harel Insurance Investments & Financial Services Ltd, established in 1933 and headquartered in Ramat Gan, Israel, is a leading provider of insurance and financial products operating across Israel, the United States, and Western Europe. The company st...
How the Company Makes Money
Harel makes money primarily through: (1) Insurance operations: It earns insurance revenue from policyholders in the form of premiums for life, health, and general (property & casualty) insurance products. Profitability in these lines is driven by und...
Harel Financial Statement Overview
Summary
Profitability rebounded strongly into 2025 and TTM with higher net income, expanding margins, and very strong ROE (~25%). Offsetting this, leverage has risen materially (debt-to-equity ~2.0x TTM) and cash-flow quality is volatile, including negative operating/free cash flow in 2024 and softer TTM free cash flow versus 2025.
Income Statement
78PositiveBalance Sheet
63PositiveCash Flow
52Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.83B | 30.63B | 27.16B | 24.86B | 12.69B | 27.49B |
| Gross Profit | 30.50B | 30.63B | 24.73B | 24.86B | 10.70B | 25.68B |
| EBITDA | 6.47B | 5.02B | 2.45B | 1.53B | 2.06B | 2.31B |
| Net Income | 3.28B | 2.99B | 946.00M | 485.00M | 906.00M | 1.21B |
Balance Sheet | ||||||
| Total Assets | 174.17B | 163.63B | 158.66B | 144.81B | 135.27B | 137.67B |
| Cash, Cash Equivalents and Short-Term Investments | 31.30B | 2.74B | 25.53B | 26.50B | 24.89B | 26.25B |
| Total Debt | 26.39B | 22.27B | 18.50B | 10.95B | 7.28B | 7.14B |
| Total Liabilities | 161.51B | 151.44B | 149.46B | 135.85B | 126.88B | 128.78B |
| Stockholders Equity | 12.63B | 12.17B | 9.12B | 8.89B | 8.34B | 8.86B |
Cash Flow | ||||||
| Free Cash Flow | 2.24B | 5.43B | -3.52B | 3.02B | 1.60B | 1.13B |
| Operating Cash Flow | 2.64B | 5.47B | -3.06B | 3.47B | 1.98B | 1.49B |
| Investing Cash Flow | -462.00M | -514.00M | -1.02B | -511.00M | -371.00M | -632.00M |
| Financing Cash Flow | -1.85B | -1.45B | 1.45B | 1.01B | -1.01B | 581.00M |
Harel Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HARL, the sentiment is Negative. The current price of 18060.00 is below the 20-day moving average (MA) of 19087.00, below the 50-day MA of 19040.02, and above the 200-day MA of 17053.67, indicating a neutral trend. The MACD of -65.55 indicates Positive momentum. The RSI at 37.72 is Neutral, neither overbought nor oversold. The STOCH value of 19.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HARL.
Harel Peers Comparison
Overall Rating
IL:IDIN80Outperform
IL:MMHD77Outperform
IL:PHOE75Outperform
IL:HARL71Outperform
IL:AYAL66Neutral
IL:CLIS65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | ILS 3.69B | 9.99 | ― | 7.59% | 3.98% | 14.95% | |
| 77Outperform | ILS 30.86B | 12.32 | ― | 3.24% | 18.14% | 49.80% | |
| 75Outperform | ILS 42.92B | 12.94 | ― | 3.25% | 10.88% | 24.40% | |
| 71Outperform | ILS 37.11B | 11.32 | 23.23% | 3.85% | 14.74% | 70.44% | |
| 66Neutral | ILS 4.70B | 9.93 | ― | 2.83% | ― | ― | |
| 65Neutral | ILS 21.75B | 9.05 | ― | 1.84% | -30.50% | 67.45% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:HARL | Harel Insurance Investments & Financial Services | 18060.00 | 7109.61 | 64.93% | |
| IL:CLIS | Clal Insurance Enterprises Holdings | 26900.00 | 9065.46 | 50.83% | |
| IL:PHOE | Phoenix Holdings Ltd. | 17000.00 | 4809.48 | 39.45% | |
| IL:MMHD | Menora Mivtachim Holdings Ltd. | 49390.00 | 18067.17 | 57.68% | |
| IL:AYAL | Ayalon Holdings Ltd. | 16580.00 | 9945.78 | 149.92% | |
| IL:IDIN | I.D.I. Insurance Company Ltd. | 24950.00 | 6556.57 | 35.65% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 07, 2026